TransMedics Group Inc (TMDX)
US Market

TransMedics Group (TMDX) Financial Statements


TransMedics Group Financial Overview

TransMedics Group's market cap is currently ―. The company's EPS TTM is $-0.774; its P/E ratio is -95.76; TransMedics Group is scheduled to report earnings on April 30, 2024, and the estimated EPS forecast is $-0.02. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 66.43M$ 52.47M$ 41.55M$ 31.38M$ 25.68M
Gross Profit$ 40.66M$ 52.47M$ 28.77M$ 20.70M$ 18.11M
EBIT$ -23.34M$ 1.52M$ -1.53M$ -5.69M$ -6.62M
EBITDA$ -21.45M$ 2.92M$ -247.00K$ -4.39M$ -5.73M
Net Income Common Stockholders$ 29.00M$ -1.00M$ -2.64M$ -6.72M$ -7.43M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 427.10M$ 582.20M$ 195.40M$ 201.20M$ 204.46M
Total Assets$ 689.23M$ 690.35M$ 287.09M$ 277.17M$ 274.87M
Total Debt$ 515.65M$ 515.01M$ 67.31M$ 67.56M$ 67.73M
Net Debt$ 88.55M$ -67.19M$ -128.09M$ -133.65M$ -136.73M
Total Liabilities$ 562.77M$ 545.14M$ 94.46M$ 277.12M$ 87.02M
Stockholders Equity$ 126.46M$ 145.23M$ 192.63M$ 187.35M$ 187.86M
Cash Flow-
Free Cash Flow$ -114.59M$ -7.18M$ -9.59M$ -6.78M$ -17.21M
Operating Cash Flow$ -6.87M$ -5.80M$ -8.66M$ -4.01M$ -14.28M
Investing Cash Flow$ -149.83M$ -1.38M$ -927.00K$ -2.76M$ 24.75M
Financing Cash Flow$ 1.52M$ 394.01M$ 3.96M$ 3.06M$ 164.22M
Currency in USD

TransMedics Group Earnings and Revenue History

TransMedics Group Debt to Assets

TransMedics Group Cash Flow

TransMedics Group Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis